Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

CMS Seeks Feedback on Drug Price Negotiation and Drug Payment Programs

September 19, 2023

Input Needed by Tomorrow: CMS issues draft guidance on new Medicare Prescription Payment Plan program

The Centers for Medicare & Medicaid Services (CMS) is seeking input on draft guidance on the Medicare Prescription Payment Plan. The draft guidance would give people with Medicare prescription drug coverage (Medicare Part D) the option to pay their out-of-pocket costs in monthly payments spread out over the year, starting in 2025.

CMS also is requesting feedback on the best ways to educate Part D enrollees about the program. Specifically, CMS is seeking input on: 

  • Which model documents or other materials CMS should develop or update; 
  • How to most effectively conduct outreach and education about the program
  • How to leverage existing resources, including the State Health Insurance Assistance Program (SHIP)
  • How to communicate about overlapping programs (such as the Low-Income Subsidy and Medicare Savings Programs)

Comments can be submitted via email until Wednesday, September 20.

Please send comments to with the subject line “Medicare Prescription Payment Plan Guidance.”

For more information on the Medicare Prescription Payment Plan, check out this fact sheet and timeline for implementation.

CMS Listening Sessions: Medicare Drug Price Negotiation Program

CMS will host a series of virtual patient-focused listening sessions this fall as part of the Medicare Drug Price Negotiation Program. The sessions will provide an opportunity for patients, beneficiaries, caregivers, consumer and patient organizations, and other interested parties to share input relevant to the drugs selected for the first round of negotiations.  

CMS is interested in patient-focused input, including information related to therapeutic alternatives of the selected drugs and how the selected drugs address unmet need, as well as how the selected drugs impact specific populations. The sessions will be listen-only; CMS will not be responding to feedback during the sessions.  

The listening sessions will be held October 30-November 15, 2023. There is one session for each of the 10 drugs selected for the first round of price negotiations. The schedule can be found on CMS’ website. Registration is not required. All sessions will be livestreamed.    

There are two ways to share feedback and input to CMS related to the selected drugs and their therapeutic alternatives:  

View additional information on the public listening sessions and the Medicare Drug Price Negotiation Program.

Last modified on 09/19/2023

Back to Top